Master in Medical Biotechnologies

Tuition is 1,606 EUR per year.

Medical biotechnology applies biological knowledge and laboratory techniques to problems in human health, spanning the development of diagnostics, therapeutics, and tools used in biomedical research. Students in this field typically study molecular biology, genetics, immunology, pharmacology, and biochemistry, alongside more technical subjects such as recombinant DNA technology, cell culture, and the production and testing of biological products. The discipline connects basic science with applied work, since discoveries made in a laboratory setting are often the starting point for new diagnostic tests, vaccines, or treatments. Medical Biotechnologies is offered as a master's degree at Universita degli Studi di Siena, in Siena, Italy, taught in English. The program follows the two-year format standard for master's degrees in the European system, allowing time for advanced coursework together with laboratory training and, typically, a research-based thesis carried out in a specific area of biomedical science. Graduates of medical biotechnology programs pursue careers in pharmaceutical and biotechnology companies, clinical and research laboratories, diagnostic companies, and regulatory bodies overseeing the approval and safety of medical products. Others continue into doctoral research, working toward academic careers or advanced positions in industry research and development. Because the field is closely tied to human health, some graduates also find roles that bridge science and clinical practice, such as working alongside physicians and researchers on translational projects that move findings from the laboratory toward clinical application. The technical and analytical skills developed during a medical biotechnology degree, including laboratory methods and data interpretation, are also transferable to broader roles in the life sciences and biomedical industries more generally.